2 completed, 2 unknown. 2 Phase 1, 2 Phase 2, 1 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Unknown 2 |
| Phase 2 | 2 | Completed 1, Unknown 1 |
| Not applicable | 1 | Completed 1 |
Follow VTBIO Co. LTD: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of Possibility of Using Regulatory T Cells(VT301) for Treatment of Alzheimer's Disease VT301 - Alzheimer Disease | Phase 1 | Unknown | VTBIO Co. LTD | 12 | 2020-11-01 | 2021-08-23 |
| A Safety and Tolerability Study of GB301 Regulatory T cells, Saline - Alzheimer Disease | Phase 1 / Phase 2 | Unknown | VTBIO Co. LTD | 20 | 2019-12-01 | 2019-08-05 |
| Study to Explore the Optimal Dosage/Administration in Alzheimer's Disease PM012, Placebo - Alzheimer's Disease | Phase 2 | Completed | VTBIO Co. LTD | 151 | 2012-05-01 | 2016-04-18 |
| Double Blinded, Randomized, Placebo-controlled Clinical Study for Nelumbinis Semen PM011 - Stress | Not applicable | Completed | VTBIO Co. LTD | 46 | 2007-06-07 | 2019-06-04 |
Nelumbinis Semen (1) · Sodium Chloride (1)
South Korea (2) · Australia (1)
Chang-Uk Lee, M.D. (1) · Hyun-Kook Lim, M.D. (1) · Jaeyoon Kim (1) · Jun-Hong Lee, M.D. (1) · Seoung-Hun Cho, M.D. (1)